TERN

$52.93-0.02 (-0.04%)

Market ClosedLast close May 1

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

Overview Intraday ResearchPRO OptionsPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO